Federation Des Caisses Desjardins Du Quebec Abb Vie Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $19 Billion
- Q1 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Abb Vie Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 165,509 shares of ABBV stock, worth $32.9 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
165,509
Previous 150,404
10.04%
Holding current value
$32.9 Million
Previous $26.7 Million
29.75%
% of portfolio
0.18%
Previous 0.15%
Shares
33 transactions
Others Institutions Holding ABBV
# of Institutions
4,255Shares Held
1.28BCall Options Held
16.1MPut Options Held
14.9M-
Vanguard Group Inc Valley Forge, PA177MShares$35.2 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.9 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.9 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$8.17 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $351B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...